{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:04:46Z","timestamp":1763755486630,"version":"3.45.0"},"reference-count":31,"publisher":"Oncology Nursing Society (ONS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ONF"],"published-print":{"date-parts":[[2015,5,1]]},"DOI":"10.1188\/15.onf.311-315","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T15:09:02Z","timestamp":1497884942000},"page":"311-315","source":"Crossref","is-referenced-by-count":1,"title":["Caring for Two: Pregnancy and Chronic Myeloid Leukemia"],"prefix":"10.1188","volume":"42","author":[{"given":"Catherine","family":"Vassili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ali, R., Ozkalemkas, F., Kimya, Y., Koksal, N., Ozkocamm, V., Gulte, T., . . . Tunali, A. (2009). Imatinib use during pregnancy and breast feeding: A case report and review of the literature. Archives of Gynecological Obstetrics, 280, 169\u2013173.","DOI":"10.1007\/s00404-008-0861-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Apperley, J. (2009). CML in pregnancy and childhood. Best Practice and Research. Clinical Haematology, 22, 445\u2013475. doi:10.1016\/j.beha.2009.09.008","DOI":"10.1016\/j.beha.2009.09.008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ault, P., Kantarjian, H., O\u2019Brien, S., Faderl, S., Beran, M., Rios, M.B., . . . Cortes, J. (2006). Pregnancy among patients with chronic myeloid leukemia treated with imatinib. Journal of Clinical Oncology, 24, 1204\u20131208. doi:10.1200\/JCO.2005.04.6557","DOI":"10.1200\/JCO.2005.04.6557"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Baccarani, M., Deininger, M.W., Rosti, G., Hochhaus, A., Soverini, S., Apperley, J.F., . . . Hehlmann, R. (2013). European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood, 122, 872\u2013884.","DOI":"10.1182\/blood-2013-05-501569"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Baccarani, M., Pileri, S., Steegmann, J.L., Muller, M., Soverini, S., & Dreyling, M. (2012). Chronic myeloid leukemia: ESMO clinic practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 23(Suppl, 7), vii72\u2013vii77. doi:10.1093\/annonc\/mds228","DOI":"10.1093\/annonc\/mds228"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Bayraktar, S., Morency, B., & Escalon, M.P. (2010). Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first \u2028trimester. BMJ Case Reports. Retrieved from http:\/\/casereports.bmj.com\/con\u2028tent\/2010\/bcr.05.2010.2975.full","DOI":"10.1136\/bcr.05.2010.2975"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Berveiller, P., Andreoli, A., Mir, O., Anselem, O., Delezoide, A.L., Sauvageon, H., . . . Tsatsaris, V. (2012). A dramatic fetal outcome following transplacental transfer of dasatinib. Anti-Cancer Drugs, 23, 754\u2013757.","DOI":"10.1097\/CAD.0b013e328352a8fe"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Cole, S., Kantarjian, H., Ault, P., & Cortes, J.E. (2009). Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: A case report and review of the literature. Clinical Lymphoma and Myeloma, 9, 324\u2013327. doi:10.3816\/CLM.2009.n.064","DOI":"10.3816\/CLM.2009.n.064"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Conchon, M., Sanabani, S.S., Bendit, I., Santos, F.M., Serpa, M., & Dorliac-Llacer, P.E. (2009). Two successful pregnancies in a woman with chronic myeoid leukaemia exposed to nilotinib during the first trimester of her second pregnancy: Case study. Journal of Hematology and Oncology, 2, 42. doi:10.1186\/1756-8722-2-42","DOI":"10.1186\/1756-8722-2-42"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Conchon, M., Sanabani, S.S., Serpa, M., Novaes, M.M.Y., Nardinelli, L., Ferreira, P.B., . . . Bendit, I. (2010). Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on dasatinib therapy. Advances in Hematology, v2010, ID362525.","DOI":"10.1155\/2010\/136252"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Cortes, J., & Kantarjian, H. (2012). How I treat newly diagnosed chronic phase CML. Blood, 120, 1390\u20131397. doi:10.1182\/blood-2012-03-378919","DOI":"10.1182\/blood-2012-03-378919"},{"key":"12","unstructured":"Cortes, J., O\u2019Brien, S., Ault, P., Borthakur, G., Jabbour, E., Bradley-Garelik, B., . . . Kantarjian, H. (2008). Pregnancy outcomes among patients with chronic myeloid leukemia treated with dasatinib [Abstract 3230]. Blood, 112. Retrieved from http:\/\/abstracts.hema tologylibrary.org\/cgi\/content\/abstract \/112\/11\/3230"},{"key":"13","unstructured":"Eskander, R.N., Tarsa, M., Herbst, K.D., & Kelly, T.F. (2011). Chronic myeloid leukemia in pregnancy: A case report describing treatment using multimodal therapy. Journal of Obstetrics and Gynaecology Research, 37, 1731\u20131733. doi:10.1111\/j.1447\u2028-0756.2011.01591.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Gentile, M., Guido, M., Lucia, E., Vigna, E., Mazzone, C., Recchia, A.G., & Morabito, F. (2014). Favourable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib. Leukemia and Lymphoma, 55, 709\u2013710.","DOI":"10.3109\/10428194.2013.811240"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hensley, M.L., & Ford, J.M. (2003). Imatinib treatment: Specific issues related to safety, fertility, and pregnancy. Seminars in Hematology, 40(Suppl., 2), 21\u201325. doi:10.1053\/shem.2003.50038","DOI":"10.1053\/shem.2003.50038"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Huang, X., Cortes, J., & Kantarjian, H. (2012). Estimates of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitors therapy. Cancer, 118, 3123\u20133127. doi:10.1002\/cncr.26679","DOI":"10.1002\/cncr.26679"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kroll, T., Ames, M.B., Pruett, J.A., & Fenske, T.S. (2010). Successful management of pregnancy occurring in a patient with chronic myeloid leukaemia on dasatinib. Leukemia and Lymphoma, 51, 1751\u20131753. doi:10.3109\/10428194.2010.497982","DOI":"10.3109\/10428194.2010.497982"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kronenberger, R., Schleyer, E., Bornhauser, M., Ehninger, G., Gattermann, N., & Blum, S. (2009). Imatinib in breast milk. Annals of Hematology, 88, 1265\u20131266. doi:10.1007\/s00277-009-0754-2","DOI":"10.1007\/s00277-009-0754-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Mahon, F.X., Rea, D., Guilhot, J., Guilhot, F., Huguet, F., Nicolini, F., . . . Rousselot, P. (2010). Discontinuation of imatinib in patients with chronic myeloid leukemia who have maintained complete molecular remission for at least 2 years: The prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncology, 11, 1029\u20131035. doi:10.1016\/S1470-2045(10)70233-3","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Milojkovic, D., & Apperley, J.F. (2014). How I treat leukemia during pregnancy. Blood, 123, 974\u2013984. doi:10.1182\/blood-2013-08-283580","DOI":"10.1182\/blood-2013-08-283580"},{"key":"21","unstructured":"National Comprehensive Cancer Network. (2014). NCCN Guidelines: Chronic myelogenous leukemia [v.3.2014]. Retrieved from http:\/\/www.nccn.org\/profession\u2028als\/physician_gls\/pdf\/cml.pdf"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Oweini, H., Otrock, Z.K., Mahfouz, R.A.R., & Bazarbachi, A. (2011). Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib. Archives of Gynecological Obstetrics, 283, 133\u2013134.","DOI":"10.1007\/s00404-010-1501-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Pavlovsky, C., Giere, I., & Thillo, G.V. (2012). Planned pregnancy in a chronic myeloid leukemia patient in molecular remission. Case Reports in Hematology. Retrieved from http:\/\/www.hindawi\u2028.com\/journals\/crihem\/2012\/624590","DOI":"10.1155\/2012\/624590"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Pye, S.M., Cortes, J., Ault, P., Hatfield, A., Kantarjian, H., Pilot, R., & Apperley, J.F. (2008). The effects of imatinib on pregnancy outcome. Blood, 111, 5505\u20135508. doi:10.1182\/blood-2007-10-114900","DOI":"10.1182\/blood-2007-10-114900"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ross, D.M., Branford, S., Seymour, J.F., Schwarer, A.P., Arthur, C., Yeung, D.T., . . . Hughes, T.P. (2013). Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: Results from the TWISTER study. Blood, 122, 515\u2013522.","DOI":"10.1182\/blood-2013-02-483750"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Russell, M.A., Carpenter, M.W., Akhtar, M.S., Lagattuta, T.F., & Egorin, M.J. (2007). Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk. Journal of Perinatology, 27, 241\u2013243. doi:10.1038\/sj.jp.7211665","DOI":"10.1038\/sj.jp.7211665"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Sawyers, C.L. (1999). Chronic myeloid leukemia. New England Journal of Medicine, 340, 1330\u20131340.","DOI":"10.1056\/NEJM199904293401706"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Shash, E., Bassi, S., Cocorocchio, E., Colpi, G.M., Cinieri, S., & Peccatori, F.A. (2011). Fatherhood during imatinib. Acta Oncologica, 50, 734\u2013735.","DOI":"10.3109\/0284186X.2011.577562"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Sora, F., Bajer, J., D\u2019alo, F., Leone, G., & Sica, S. (2009). Persistence of molecular remission throughout pregnancy in CML after imatinib. Leukemia Research, 33, e6\u2013e7. doi:10.1016\/j.leukres.2008.09.012","DOI":"10.1016\/j.leukres.2008.09.012"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Yazdani-Brojeni, P., Matok, I., Garcia Bourissen, F., & Koren, G. (2012). A systematic review of the fetal safety of interferon alpha. Reproductive Toxicology, 33, 265\u2013268. doi:10.1016\/j.reprotox.2011.11.003","DOI":"10.1016\/j.reprotox.2011.11.003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Zhou, L., You, J.H., Wu, W., Li, J.M., Shen, Z.X., & Wang, A.H. (2013). Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor. Leukemia Research, 37, 1216\u20131221.","DOI":"10.1016\/j.leukres.2013.07.020"}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/onf.ons.org\/onf\/42\/3\/caring-two-pregnancy-and-chronic-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:53:22Z","timestamp":1763754802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/42\/3\/caring-two-pregnancy-and-chronic-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1188\/15.onf.311-315","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"type":"print","value":"0190-535X"},{"type":"electronic","value":"1538-0688"}],"subject":[],"published":{"date-parts":[[2015,5,1]]}}}